Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides.



Similar documents
DM Management in Elderly- What are the glucose targets?

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

Management of Diabetes in the Elderly. Sylvia Shamanna Internal Medicine (R1)

INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?

CASE B1. Newly Diagnosed T2DM in Patient with Prior MI

Intensive Insulin Therapy in Diabetes Management

Diabetes Complications

Presented By: Dr. Nadira Husein

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

Insulin Therapy In Type 2 DM. Sources of support. Agenda. Michael Fischer, M.D., M.S. The underuse of insulin Insulin definition and types

SHORT CLINICAL GUIDELINE SCOPE

INSULIN TREATMENT FOR TYPE 2 DIABETES MANAGEMENT

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

Diagnosis, classification and prevention of diabetes

CASE A1 Hypoglycemia in an Elderly T2DM Patient with Heart Failure

When and how to start insulin: strategies for success in type 2 diabetes

Therapy Insulin Practical guide to Health Care Providers Quick Reference F Diabetes Mellitus in Type 2

Intensifying Insulin Therapy

Diabetes Management Tube Feeding/Parenteral Nutrition Order Set (Adult)

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

The basal plus strategy. Denis Raccah, MD, PhD Professor of Medicine University Hospital Sainte Marguerite Marseille FRANCE

Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

Britni Hebert, MD PGY-1

Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children

Quick Reference Guide

INSULIN INTENSIFICATION: Taking Care to the Next Level

Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours

Treatment Approaches to Diabetes

Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge

Algorithms for Glycemic Management of Type 2 Diabetes

Section 5: Type 2 Diabetes

Managing Patients Newly Diagnosed with Diabetes. Sud Dharmalingam MD, FRCPC Staff Endocrinologist William Osler Health System Brampton, ON

Diabetes mellitus. Lecture Outline

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner

Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes

Distinguishing between Diabetes Mellitus Type 1 and Type 2, (with Overview of Treatment Strategies)

Glucose Tolerance Categories. Distinguishing between Diabetes Mellitus Type 1 and Type 2, (with Overview of Treatment Strategies)

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

Is Insulin Effecting Your Weight Loss and Your Health?

Diabetes Medications: Insulin Therapy

Type 2 diabetes is a progressive. status

June Fowler Brill, RN, CDE UC San Diego Diabetes and Pregnancy Program

Insulin switch & Algorithms Rotorua GP CME June Kingsley Nirmalaraj FRACP Endocrinologist BOPDHB

Diabetes in the elderly. Chris MacKnight April 2, 2011

Diabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW

BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS

Diabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

Diabetes and the Elimination of Sliding Scale Insulin. Date: April 30 th Presenter: Derek Sanders, D.Ph.

Adult Diabetes Clinician Guide

Prior Authorization Guideline

Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians

Long term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO

Cardiovascular Effects of Drugs to Treat Diabetes

trends in the treatment of Diabetes type 2 - New classes of antidiabetic drugs. IAIM, 2015; 2(4): 223-

Type 2 Diabetes. Jonathon M. Firnhaber, MD. Assistant Professor, Residency Program Director East Carolina University Greenville, North Carolina

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or

Treatment of Type 2 Diabetes

Abdulaziz Al-Subaie. Anfal Al-Shalwi

Novel Trial Designs in T2D to Satisfy Regulatory Requirements for CV Safety

Statins and Risk for Diabetes Mellitus. Background

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks

Diabetes Fundamentals

The Arguments: T2DM - tremendous economic burden globally Lifestyle / Pharm Rx:

Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins

Type 2 Diabetes in Children

Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes

Inpatient Treatment of Diabetes

Antihyperglycemic Agents Comparison Chart

Cardiovascular Disease in Diabetes

The Canadian Diabetes Association s 2013 Clinical Practice Guidelines and the Pharmacist Rob Roscoe, B.Sc.Pharm., ACPR, CDE, CPT

Diabetes DIABETES MELLITUS. Types of Diabetes. Classification of Diabetes Prediabetes: IFG, IGT, Increased A1C

Insulin Analogues versus Pump Therapy in Type 2 Diabetes: Benefits from Pump Therapy

Starting Insulin Sooner Than Later

Diabetes Prevention in Latinos

A prospective study on drug utilization pattern of anti-diabetic drugs in rural areas of Islampur, India

Glycemic Control of Type 2 Diabetes Mellitus

Safety & Effectiveness of Drug Therapies for Type 2 Diabetes: Are pharmacoepi studies part of the problem, or part of the solution?

Update on the management of Type 2 Diabetes

Updates for your practice March, Vol 2, Issue 14 TLALELETSO. Managing Complicated Diabetes

Insulin or GLP1 How to make this choice in Practice. Tara Kadis Lead Nurse - Diabetes & Endocrinology Mid Yorkshire Hospitals NHS Trust

David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010

Diabetes and Obesity. The diabesity epidemic

Insulin Treatment. J A O Hare. Bones, Brains & Blood Vessels

PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.

Diabetes Dispatch. Children with Type 2 Diabetes: How do we treat them? A L A S K A N A T I V E D I A B E T E S T E A M. Inside this issue:

Gayle Curto, RN, BSN, CDE Clinical Coordinator

The first injection of insulin was given on

Initiating & titrating insulin & switching in General Practice Workshop 1

Are insulin analogs worth their cost in type 2 diabetes?

Management of Diabetes: A Primary Care Perspective. Presentation Outline

Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS

Second- and Third-Line Approaches for Type 2 Diabetes Workgroup: Topic Brief

Department Of Biochemistry. Subject: Diabetes Mellitus. Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage.

Insulin/Diabetes Calculations

Vascular Risk Reduction: Addressing Vascular Risk

There seem to be inconsistencies regarding diabetic management in

PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison

Transcription:

Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides. Example: = Head Over Heels

Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides. Example: = Head Over Heels

Diabetes in the Elderly How should the new CDA Guidelines affect our practice?

Faculty Disclosure Faculty: Dr. Rob Silver Relationships with commercial interests: None

Learning Objectives 1. When and who should we screen for diabetes in the elderly? 2. What are the current treatment targets? 3. How does frailty and/or cognitive impairment affect our goals of therapy?.

Q: How common is diabetes in the elderly? A: 20% Why? Obesity Inactivity Decreased muscle mass Co-morbid illness Diet Medications Beta cell senescence?

Mechanisms of Age-Related Glucose Intolerance Delayed glucose-induced insulin secretion Impaired insulin suppression of HGO Impaired insulin-mediated muscle glucose uptake Decreased number of glucose transporters Diabetes Care (11) Supp 2;9-19,1990

Screening for Diabetes in the Elderly FPG- 0.1 mmol/l increase per decade Diabetes 36:523-34,1987 HgbA1C- 0.014 unit increase per year Diabetes Care 31(10):1991-1996,2008 (FOS and NHANES) 2 Hr. GTT- 0.3-0.6 mmol/l increase per decade 0.5 mmol/l higher for women Med Clin N Am 55:835-45,1971 Discordance between FPG and A1C based Dx JCEM 95:5289-95, 2010

Screening of the Healthy Elderly Age > 40 years First-degree relative with Type 2 DM Member of high-risk population History of pre-diabetes History of GDM Presence of DM complications Presence of vascular risk factors Associated diseases- PCOS, HIV, OSA, Psychiatric disorders, Acanthosis nigricans Medications associated with DM

Screening of the Frail Elderly In the absence of positive intervention studies on morbidity or mortality in this population, the decision about screening for diabetes should be made on an individual basis. Canadian Journal of Diabetes- 37:3 June, 2013

All of the following statements are true, except: A. Diabetes and prediabetes may affect up to 40% of persons more than age 65. B. Insulin resistance is a characteristic of the elderly. C. Type 1 diabetes is never seen in the elderly. D. Reduced muscle glucose transport accounts for the majority of IGT in the elderly.

All of the following statements are true, except: A. Diabetes and prediabetes may affect up to 40% of persons more than age 65. B. Insulin resistance is a characteristic of the elderly. C. Type 1 diabetes is never seen in the elderly. D. Reduced muscle glucose transport accounts for the majority of IGT in the elderly.

Current Treatment Targets Referral to a Diabetes Education Centre Age Ageing:390-396, 2009 Telemedicine and web-based case management J Am Med Inform Assoc 16:446-456,2009 Diabetes Technol Ther 9:52-59, 2007 Pharmaceutical Care Program Int J Clin Pharm 33:642-49, 2011

Current Treatment Targets Same glycemic targets for the healthy elderly as for younger people with diabetes. Intensive control reduces microvascular, though not macrovascular risk or mortality. NEJM 358:2545-59, 2008 Associated with less disability and better function Diabetes Care 33:1055-60, 2010 PC BG a better predictor than AC BG or A1C BG variability associated with worse cognition Diabetes Care 33:2169-74, 2010

Current Treatment Targets Aging is a risk factor for severe hypoglycemia with intensive therapy. BMJ 340:b5444, 2010 Asymptomatic hypoglycemia frequent in this group Arch Intern Med 171:362-64, 2011 Cognitive dysfunction is a significant risk factor. Diabetologia 52:2328-36, 2009 Prevent hypoglycemia as much as possible.

Nutrition and Physical Activity Nutrition education programs can improve metabolic control. Prev Med 34:252-59, 2002 Amino acid supplementation may improve glycemic control and insulin sensitivity. Careful CV and MSK evaluation prior to an exercise program. Resistance training improves BG control, strength and mobility. Diabetes Care 25:1729-35, 2002 Supervision required to maintain lifestyle changes. Diabetes Care 28:3-9, 2005

Oral Antihyperglycemic Agents Obese elderly- Metformin- no randomized trial evidence in the elderly. Alpha-glucosidase inhibitors- modestly effective, but intolerable for many. TZD s- effective, but increased risk of CHF and fracture risk in women. Metformin and TZD s reduce loss of muscle mass. Diabetes Care 34:2381-86, 2011 Sulfonylureas- risk of severe hypoglycemia increases with age. Gliclazide safer than Glyburide. (DPP)-4 inhibitors- less hypoglycemia and wt. gain.

Insulin Therapy Should be individualized for patient safety. Predictive value of clock drawing test. CJD 29:102-04, 2005 Premixed insulins and prefilled insulin pens minimize dosing errors. Premixed insulin analogues result in equivalent BG control to basal-bolus regimens. Japan Clin Drug Invest 30:35-40, 2010 Addition of Glargine to oral agents- effective and safer compared to escalation of OHA s. Acta Diabetol 45:53-59, 2008

Which of the following is a false statement? A. Glycemic targets for the healthy elderly should be similar to younger people with diabetes. B. Glargine should not be used in the elderly because of cancer risk. C. Metformin should not be used with a GFR< 30. D. Resistance training may improve BG control, strength and mobility.

Which of the following is a false statement? A. Glycemic targets for the healthy elderly should be similar to younger people with diabetes. B. Glargine should not be used in the elderly because of cancer risk. C. Metformin should not be used with a GFR< 30. D. Resistance training may improve BG control, strength and mobility.

J Gerontol Med Sci 56A:146-56, 2001 Frailty and/or Cognitive Impairment A multi-dimensional syndrome that gives rise to increased vulnerability. Fried s Frailty Phenotype Unintentional wt. loss (>10 lbs. in the past year) Self reported exhaustion Grip strength weakness Slow walking speed Low physical activity

Frailty and/or Cognitive Impairment Progressive frailty assoc. with increased mortality Older patients with diabetes are more likely to be frail. J Am Geriatr Soc 57:840-47, 2009 Frailty- a better predictor of complications and death in elderly patients with diabetes than is chronologic age or burden of comorbidity Diabet Med 27:603-06, 2010

Frailty and/or Cognitive Impairment Clinical Frailty Scale- Rockwood et al A 9-point frailty scale 1= Very Fit 9= Terminally ill JR Coll Physicians Edinb 42:333-40, 2012 Frailty = a high level of functional dependency and limited life expectancy- benefit of intensive control is likely to be minimal. Ann Intern Med 149:11-19, 2008 The decision for stringent glycemic control should be based on the degree of frailty.

Long Term Care Facilities Diabetes often undiagnosed in these patients A high prevalence in institutions Antipsychotic drug use a major risk factor Wide variation of glycemic control Frequent use of insulin sliding scales despite lack of evidence of efficacy. Regular vs. diabetic diet- no diff. in level of glycemic control. Am J Clin Nutr- 51:67-71, 1990 Use of bolus analogue vs. regular insulin improves A1C with less hypoglycemia. Diabetes Nutri Metab 15:96-100, 2002

Which of the following is a true statement? A. Diabetic ketoacidosis is seen more frequently in the elderly. B. Tighter glycemic control reduces the risk of myocardial infarction in the elderly. C. HgbA1C never should be less than 8.5% in the elderly patient with diabetes. D. Insulin resistance in the elderly is due to diminished numbers of glucose transporters.

Which of the following is a true statement? A. Diabetic ketoacidosis is seen more frequently in the elderly. B. Tighter glycemic control reduces the risk of myocardial infarction in the elderly. C. HgbA1C never should be less than 8.5% in the elderly patient with diabetes. D. Insulin resistance in the elderly is due to diminished numbers of glucose transporters.

5. Use Sulfonylureas with caution..gliclazide instead of Glyburide. May consider Meglitinides or DPP-4 inhibitors. Summary and Conclusions 1. Healthy elderly people should achieve the same glycemic control as younger people with diabetes. 2. In the frail elderly, HgbA1C < 8.5%, AC BG of <10 PC BG <14. Avoiding Hypos takes priority. 3. With cognitive impairment, strictly avoid hypoglycemia. 4. Aerobic exercise and/or resistance training will improve BG control.

Summary and Conclusions 6. TZD s should be used with caution. 7. Detemir or Glargine may be used instead of NPH or 30/70 to reduce the risk of hypoglycemia. 8. Premixed insulins and prefilled insulin pens are preferable to manual mixing of insulin to reduce dosing errors. 9. The clock drawing test has predictive value regarding difficulty learning to inject insulin. 10. In LTC, regular diets may be used instead of diabetic diets.

Diabetes in the Elderly How should the new CDA Guidelines affect our practice?